Obesity in Renal Transplantation

Nephron. 2021;145(6):614-623. doi: 10.1159/000515786. Epub 2021 May 11.

Abstract

Background: Data from the WHO show an increasing rate of overweight and obesity in general population in the last decades. This increase in obesity also affects population with end-stage renal disease (ESRD) and kidney transplant (KT) candidates.

Summary: In this review, we focused on how obesity impacts on KT stages: access to KT and outcomes of KT candidates; how to reduce weight and its consequences; short and long-term outcomes in obese recipients and the impact of weight variations; and the implications of obesity in living donor KT. We searched MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials until November 30, 2020. We selected systematic reviews and meta-analyses and randomized clinical trials. When no such reports were found for a topic, observational studies were included in the assessment. Key Messages: Although obesity is a risk factor to present worst outcomes after KT, several studies have demonstrated a survival benefit compared to patients who continue on dialysis. There is a need for a public health campaign to raise awareness in KT candidates and to highlight the importance of self-care, increasing exercise, healthy diet, and weight loss.

Keywords: Kidney transplantation; Obesity; Review.

Publication types

  • Review

MeSH terms

  • Anti-Obesity Agents / therapeutic use
  • Bariatric Surgery
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation*
  • Obesity / complications*
  • Obesity / drug therapy
  • Obesity / surgery
  • Tissue Donors
  • Treatment Outcome
  • Weight Loss

Substances

  • Anti-Obesity Agents